P1102: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: UPDATED OUTCOMES FROM A MULTICENTRE, REAL-WORLD UK STUDY.

التفاصيل البيبلوغرافية
العنوان:	P1102: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: UPDATED OUTCOMES FROM A MULTICENTRE, REAL-WORLD UK STUDY.
المؤلفون:	Shotton, Rohan, Tivey, Ann, Eyre, Toby A., Lewis, David, Allchin, Rebecca, Walter, Harriet, Miall, Fiona, Zhao, Rui, Santarsieri, Anna, Mcculloch, Rory, Bishton, Mark, Willimott, Victoria, Fowler, Nicole, Bedford, Claudia, Goddard, Jack, Protheroe, Samuel, Prahladan, Mahesh, Reeve, Miriam, Paneesha, Shankara, Marr, Helen
المصدر:	HemaSphere; 2023 Supplement 3, Vol. 7, pe816878d-e816878d, 1p
قاعدة البيانات:	Complementary Index

كن أول من يترك تعليقا!